Clinical trial reportLung cancer (Amsterdam, Netherlands)Published
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Lung cancer (Amsterdam, Netherlands)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Quinolines; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; Mutation; Adult
- PubMed ID
- 41689889
- Added to directory
- Source checked